In 2019, the global contract development and manufacturing organizations (CDMO) market was valued at about €139.9B ($151B). By 2025, it is estimated to...
TEKLYNX CENTRAL improved labeling accuracy and compliance by 100% for global biotech company bioMérieux TEKLYNX CENTRAL has improved labeling efficiency...
“(The) FDA’s emergency authorization of remdesivir, two days after the National Institutes of Health’s clinical trial showed promising results, is a significant step...
The Dutch biotech argenx has cashed in on recent positive phase III results by launching an enormous €784.7M ($862.5M) global share offering.
Argenx’s fundraise...
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis and Parkinson’s disease, has launched in Barcelona with...
As the biotech industry flourishes and therapies become more targeted and personalized, the need for drug developers to interact with patients is increasing...
